Insulet Co. (NASDAQ:PODD – Get Rating) – Research analysts at William Blair issued their Q1 2024 earnings estimates for Insulet in a note issued to investors on Thursday, May 25th. William Blair analyst M. Kaczor forecasts that the medical instruments supplier will post earnings of $0.32 per share for the quarter. The consensus estimate for […]
Insulet Co. (NASDAQ:PODD – Get Rating) has received a consensus rating of “Hold” from the fourteen research firms that are presently covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among brokerages that […]
Cigna Investments Inc. New acquired a new position in shares of Insulet Co. (NASDAQ:PODD – Get Rating) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 747 shares of the medical instruments supplier’s stock, valued at approximately $220,000. A number of other hedge […]
Simplify Asset Management Inc. bought a new stake in Insulet Co. (NASDAQ:PODD – Get Rating) in the 4th quarter, HoldingsChannel reports. The firm bought 873 shares of the medical instruments supplier’s stock, valued at approximately $257,000. Several other large investors also recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew […]
Insulet Co. (NASDAQ:PODD – Get Rating) shares were down 5.6% during trading on Thursday . The stock traded as low as $274.26 and last traded at $277.23. Approximately 204,643 shares changed hands during mid-day trading, a decline of 71% from the average daily volume of 711,383 shares. The stock had previously closed at $293.75. Analyst […]